New PBS listing to ease burden of inflammatory bowel disease The listing of the treatment of moderate-to-severe ulcerative colitis is a key step in helping thousands of Australians.
Close the Gap PBS Co-payment changes a ‘positive step forward’ The RACGP has welcomed changes that aim to improve Aboriginal and Torres Strait Islander peoples’ access to subsidised medicines.
COVID’s impact on health service usage, rebates and scripts How many MBS services have been used, PBS prescriptions dispensed, and Government benefits paid during the pandemic?
‘Serious implications’ if menopause treatments removed from PBS Experts warn the proposed delisting of medications will not only impose cost-related issues, but potentially affect quality of life.
Active Ingredient Prescribing to become mandatory from 1 February GPs have been reminded to update their clinical software in order to continue issuing legal prescriptions.
Has the pandemic changed the way people utilise health services? The AIHW has released a series of reports outlining how COVID-19 changed the way Australians used health services in 2019–20.
PBS update provides new options for people with CVD and leukaemia The latest changes have been hailed as ‘exciting’ and an ‘important milestone’ by specialists.
An antidepressant is now one of Australia’s most commonly prescribed drugs – but why? Nuance is necessary to interpret why prescriptions of sertraline have gone up, according to an expert.
Stigma limiting hepatitis C treatment Uptake has slowed despite Australians having access to highly effective treatment.
PBS to provide access to life-saving MS and cancer medicines New medicines for multiple sclerosis and various cancers will be available on the Pharmaceutical Benefits Scheme from 1 November.